Using proteomic and genomic methods to understand JDM

Rie Karasawa; James N. Jarvis

doi:10.2177/jsci.38.150

Using proteomic and genomic methods to understand JDM

Rie Karasawa
, James N. Jarvis

Pediatrics

SUNY Buffalo
St. Marianna University School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Juvenile dermatomyositis is a complex illness characterized by vascular/perivascular inflammation, primarily in the skin and muscles. In this review, we discuss how proteomic and genomic technologies have expanded our understanding of the immune pathogenesis of this disease. We will also discuss further directions that the field may take to use existing and developing technologies to further our understanding of this often-perplexing disease.

Original language	English
Pages (from-to)	150-156
Number of pages	7
Journal	Japanese Journal of Clinical Immunology
Volume	38
Issue number	3
DOIs	https://doi.org/10.2177/jsci.38.150
State	Published - Jul 23 2015

Keywords

Anti-endothelial cell antibodies (AECA)
Gene expression profiling
Genomics
Juvenile dermatomyositis
Proteomics

Access to Document

10.2177/jsci.38.150

Cite this

@article{a41d7732bdde4aa4a30555588835eb95,

title = "Using proteomic and genomic methods to understand JDM",

abstract = "Juvenile dermatomyositis is a complex illness characterized by vascular/perivascular inflammation, primarily in the skin and muscles. In this review, we discuss how proteomic and genomic technologies have expanded our understanding of the immune pathogenesis of this disease. We will also discuss further directions that the field may take to use existing and developing technologies to further our understanding of this often-perplexing disease.",

keywords = "Anti-endothelial cell antibodies (AECA), Gene expression profiling, Genomics, Juvenile dermatomyositis, Proteomics",

author = "Rie Karasawa and Jarvis, \{James N.\}",

note = "Publisher Copyright: {\textcopyright} 2015 The Japan Society for Clinical Immunology",

year = "2015",

month = jul,

day = "23",

doi = "10.2177/jsci.38.150",

language = "English",

volume = "38",

pages = "150--156",

journal = "Japanese Journal of Clinical Immunology",

issn = "0911-4300",

publisher = "Japan Society for Clinical Immunology",

number = "3",

}

TY - JOUR

T1 - Using proteomic and genomic methods to understand JDM

AU - Karasawa, Rie

AU - Jarvis, James N.

PY - 2015/7/23

Y1 - 2015/7/23

N2 - Juvenile dermatomyositis is a complex illness characterized by vascular/perivascular inflammation, primarily in the skin and muscles. In this review, we discuss how proteomic and genomic technologies have expanded our understanding of the immune pathogenesis of this disease. We will also discuss further directions that the field may take to use existing and developing technologies to further our understanding of this often-perplexing disease.

AB - Juvenile dermatomyositis is a complex illness characterized by vascular/perivascular inflammation, primarily in the skin and muscles. In this review, we discuss how proteomic and genomic technologies have expanded our understanding of the immune pathogenesis of this disease. We will also discuss further directions that the field may take to use existing and developing technologies to further our understanding of this often-perplexing disease.

KW - Anti-endothelial cell antibodies (AECA)

KW - Gene expression profiling

KW - Genomics

KW - Juvenile dermatomyositis

KW - Proteomics

UR - https://www.scopus.com/pages/publications/84937706228

U2 - 10.2177/jsci.38.150

DO - 10.2177/jsci.38.150

M3 - Review article

C2 - 26213193

AN - SCOPUS:84937706228

SN - 0911-4300

VL - 38

SP - 150

EP - 156

JO - Japanese Journal of Clinical Immunology

JF - Japanese Journal of Clinical Immunology

IS - 3

ER -

Using proteomic and genomic methods to understand JDM

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this